These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 17076599)

  • 1. Delivery of lysosomal enzymes for therapeutic use: glucocerebrosidase as an example.
    Grabowski GA
    Expert Opin Drug Deliv; 2006 Nov; 3(6):771-82. PubMed ID: 17076599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of mannose chain length on targeting of glucocerebrosidase for enzyme replacement therapy of Gaucher disease.
    Van Patten SM; Hughes H; Huff MR; Piepenhagen PA; Waire J; Qiu H; Ganesa C; Reczek D; Ward PV; Kutzko JP; Edmunds T
    Glycobiology; 2007 May; 17(5):467-78. PubMed ID: 17251309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic enzyme delivery by blood-brain barrier-penetrating SapC-DOPS nanovesicles for treatment of neuronopathic Gaucher disease.
    Sun Y; Liou B; Chu Z; Fannin V; Blackwood R; Peng Y; Grabowski GA; Davis HW; Qi X
    EBioMedicine; 2020 May; 55():102735. PubMed ID: 32279952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of acid beta-glucosidase with pharmacological chaperone provides insight into Gaucher disease.
    Lieberman RL; Wustman BA; Huertas P; Powe AC; Pine CW; Khanna R; Schlossmacher MG; Ringe D; Petsko GA
    Nat Chem Biol; 2007 Feb; 3(2):101-7. PubMed ID: 17187079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzyme replacement therapy for Gaucher disease.
    Charrow J
    Expert Opin Biol Ther; 2009 Jan; 9(1):121-31. PubMed ID: 19063698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic delivery of recombinant glucocerebrosidase enzyme-containing extracellular vesicles to human cells from Gaucher disease patients.
    Janpipatkul K; Sutjarit N; Tangprasittipap A; Chaiamarit T; Innachai P; Suksen K; Chokpanuwat T; Tim-Aroon T; Anurathapan U; Jearawiriyapaisarn N; Tubsuwan A; Bowornpinyo S; Asavapanumas N; Chairoungdua A; Bhukhai K; Hongeng S
    Orphanet J Rare Dis; 2024 Oct; 19(1):363. PubMed ID: 39358794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progranulin Recruits HSP70 to β-Glucocerebrosidase and Is Therapeutic Against Gaucher Disease.
    Jian J; Tian QY; Hettinghouse A; Zhao S; Liu H; Wei J; Grunig G; Zhang W; Setchell KDR; Sun Y; Overkleeft HS; Chan GL; Liu CJ
    EBioMedicine; 2016 Nov; 13():212-224. PubMed ID: 27789271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The LIMP-2/SCARB2 binding motif on acid β-glucosidase: basic and applied implications for Gaucher disease and associated neurodegenerative diseases.
    Liou B; Haffey WD; Greis KD; Grabowski GA
    J Biol Chem; 2014 Oct; 289(43):30063-74. PubMed ID: 25202012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of active human glucocerebrosidase in seeds of Arabidopsis thaliana complex-glycan-deficient (cgl) plants.
    He X; Galpin JD; Tropak MB; Mahuran D; Haselhorst T; von Itzstein M; Kolarich D; Packer NH; Miao Y; Jiang L; Grabowski GA; Clarke LA; Kermode AR
    Glycobiology; 2012 Apr; 22(4):492-503. PubMed ID: 22061999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging of enzyme replacement therapy using PET.
    Phenix CP; Rempel BP; Colobong K; Doudet DJ; Adam MJ; Clarke LA; Withers SG
    Proc Natl Acad Sci U S A; 2010 Jun; 107(24):10842-7. PubMed ID: 20534487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modifying exogenous glucocerebrosidase for effective replacement therapy in Gaucher disease.
    Brady RO; Murray GJ; Barton NW
    J Inherit Metab Dis; 1994; 17(4):510-9. PubMed ID: 7967500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated plasma glucosylsphingosine in Gaucher disease: relation to phenotype, storage cell markers, and therapeutic response.
    Dekker N; van Dussen L; Hollak CE; Overkleeft H; Scheij S; Ghauharali K; van Breemen MJ; Ferraz MJ; Groener JE; Maas M; Wijburg FA; Speijer D; Tylki-Szymanska A; Mistry PK; Boot RG; Aerts JM
    Blood; 2011 Oct; 118(16):e118-27. PubMed ID: 21868580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacological chaperone isofagomine increases the activity of the Gaucher disease L444P mutant form of beta-glucosidase.
    Khanna R; Benjamin ER; Pellegrino L; Schilling A; Rigat BA; Soska R; Nafar H; Ranes BE; Feng J; Lun Y; Powe AC; Palling DJ; Wustman BA; Schiffmann R; Mahuran DJ; Lockhart DJ; Valenzano KJ
    FEBS J; 2010 Apr; 277(7):1618-38. PubMed ID: 20148966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative therapeutic effects of velaglucerase alfa and imiglucerase in a Gaucher disease mouse model.
    Xu YH; Sun Y; Barnes S; Grabowski GA
    PLoS One; 2010 May; 5(5):e10750. PubMed ID: 20505772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzyme Replacement Therapy for Lysosomal Storage Diseases.
    Kleppin S
    J Infus Nurs; 2020; 43(5):243-245. PubMed ID: 32881810
    [No Abstract]   [Full Text] [Related]  

  • 16. Mechanism of glucocerebrosidase activation and dysfunction in Gaucher disease unraveled by molecular dynamics and deep learning.
    Romero R; Ramanathan A; Yuen T; Bhowmik D; Mathew M; Munshi LB; Javaid S; Bloch M; Lizneva D; Rahimova A; Khan A; Taneja C; Kim SM; Sun L; New MI; Haider S; Zaidi M
    Proc Natl Acad Sci U S A; 2019 Mar; 116(11):5086-5095. PubMed ID: 30808805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and characterization of ambroxol as an enzyme enhancement agent for Gaucher disease.
    Maegawa GH; Tropak MB; Buttner JD; Rigat BA; Fuller M; Pandit D; Tang L; Kornhaber GJ; Hamuro Y; Clarke JT; Mahuran DJ
    J Biol Chem; 2009 Aug; 284(35):23502-16. PubMed ID: 19578116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plant-based oral delivery of β-glucocerebrosidase as an enzyme replacement therapy for Gaucher's disease.
    Shaaltiel Y; Gingis-Velitski S; Tzaban S; Fiks N; Tekoah Y; Aviezer D
    Plant Biotechnol J; 2015 Oct; 13(8):1033-40. PubMed ID: 25828481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Production of Human β-Glucocerebrosidase in
    Naphatsamon U; Ohashi T; Misaki R; Fujiyama K
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29986415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of glucocerebrosidase with terminal mannose glycans for enzyme replacement therapy of Gaucher's disease using a plant cell system.
    Shaaltiel Y; Bartfeld D; Hashmueli S; Baum G; Brill-Almon E; Galili G; Dym O; Boldin-Adamsky SA; Silman I; Sussman JL; Futerman AH; Aviezer D
    Plant Biotechnol J; 2007 Sep; 5(5):579-90. PubMed ID: 17524049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.